Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid |
| |
Authors: | A L Barry T L Gavan R N Jones L W Ayers P C Fuchs E H Gerlach C Thornsberry |
| |
Affiliation: | Clinical Microbiology Institute, Tualatin, OR 97062. |
| |
Abstract: | ![]() A six-laboratory collaborative study was performed in order to define quality control limits for microdilution tests with seven new beta-lactams (aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid). Four standard control strains were tested and the expected MIC limits for each of the appropriate drug-microorganism combinations were defined. |
| |
Keywords: | |
|
|